L

Lionco Pharmaceutical Group Co Ltd
SSE:603669

Watchlist Manager
Lionco Pharmaceutical Group Co Ltd
SSE:603669
Watchlist
Price: 4.99 CNY -1.58% Market Closed
Market Cap: 3.6B CNY

Lionco Pharmaceutical Group Co Ltd
Investor Relations

Lionco Pharmaceutical Group Co., Ltd. engages in the sale of chemical drug and antibiotic agents. The company is headquartered in Shannan, Xizang and currently employs 678 full-time employees. The company went IPO on 2015-05-28. is a China-based company principally engaged in the research and development, production and sales of chemical prescription medicine. The firm's products are mainly categorized in to three areas: parenteral nutrition agents, anti-infectious agents and digestive system agents. The lead product of its parenteral nutrition agents is Glutamine for injection; its anti-infectious agents include Cefodizime sodium for injection and Cefathiamidine for injection, among others; its digestive system agents include Omeprazole Sodium for injection and others. The firm operates its business in domestic market.

Show more
Loading
603669
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Ms. Ling Ping Tao
GM & Chairman of the Board
No Bio Available
Mr. Jun Ke Zhang
Accounting Supervisor, Financial Director & Secretary of the Board of Directors
No Bio Available
Mr. Xiao Gang Tao
Deputy GM & Director
No Bio Available

Contacts

Address
XIZANG
Shannan
1F, Building 2, Naidong County Commercial and Residential Building, No. 68, Naidong Road, Zedang Town
Contacts
+868937830999
www.lingkang.com.cn